1. BAUMGARTNER RN, KOEHLER KM, GALLAGHER D, ROMERO L, HEYMSFIELD SB, ROSS RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiology. 1998; 147:755-63.10.1093/oxfordjournals.aje.a0095209554417
2. CESARİ M, KRITCHEVSKY SB, NEWMAN AB, SIMONSICK EM, HARRIS TB, PENNİNX BW, et al. Added value of physical performance measures in predicting adverse health-related events: results from the health, aging and body composition study. J Am Geriatr Soc 2009; 57: 251.10.1111/j.1532-5415.2008.02126.x269565319207142
5. SHAW JE, SICREE RA, ZIMMET PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.10.1016/j.diabres.2009.10.00719896746
6. WANG H, HAI S, CAO L, ZHOU J, LIU P, DONG B-R. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people. BMC Geriatrics. 2016; 16:216.10.1186/s12877-016-0386-z519849428031025
7. WANG T, FENG X, ZHOU J, GONG H, XİA S, WEİ Q, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep. 2016 Dec 13; 6:38937.10.1038/srep38937515361627958337
8. KIM TN, PARK MS, YANG SJ, YOO HJ, KANG HJ, SONG W, SEO JA, KIM SG, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010 Jul; 33 (7):1497-9.10.2337/dc09-2310289034820413515
10. PARK SW, GOODPASTER BH, STROTMEYER ES, KULLER LH, BROUDEAU R, KAMMERER C, et al. Health, aging, and body composition study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007; 30:1507-1512.10.2337/dc06-253717363749
11. PARK SW, GOODPASTER BH, LEE JS, KULLER LH, BOUDREAU R, DE REKENEIRE N, et al., Health, aging, and body composition study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009; 32:1993-1997.10.2337/dc09-0264276819319549734
12. SAYER AA, DENNİSON EM, SYDDALL HE, GILBODY HJ, PHILLIPS DI, COOPER C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care. 2005; 28:2541-2542.10.2337/diacare.28.10.254116186295
13. FUKUDA T, BOUCHI R, TAKEUCHİ T, NAKANO Y, MURAKAMI M, MINAMI I, et al. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study. BMJ Open Diabetes Research & Care. 2017; 5 (1):e000404.10.1136/bmjdrc-2017-000404553025028761661
14. CHEN LK, LıU LK, WOO J ASSANTACHAI P, AUYEUNG TW, BAHYAH KS, et al. Sarcopenia in Asia: consensus report of the asian working group for sarcopenia. J AmMed Dir Assoc 2014; 15: 95-101.10.1016/j.jamda.2013.11.02524461239
15. BAHAT G, TUFAN A, TUFAN F, KILIC C, AKPINAR TS, KOSE M, et al. “Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People [EWGSOP] definition.” Clin Nutr 2016; 35 (6): 1557-1563.10.1016/j.clnu.2016.02.00226922142
16. LANDI F, LİPEROTI R, FUSCO D MASTROPAOLO S, QUATTROCIOCCHI D, PROIA A, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012; 67: 48-55.10.1093/gerona/glr03521393423
17. YU R, WONG M, LEUNG J, LEE J, AUYEUNG TW, WOO J. Prevalence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int 2014; 14 [Suppl 1]: 15-28.10.1111/ggi.1222024450557
20. KOHARA K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine. 2014; 45:15-25.10.1007/s12020-013-9992-023821364